Martin Shkreli
martin@martinshkreli.com
←
|
PFE.xlsx
|
Failures
Master Pipeline
Approved Products
Management
Main
Model
Comirnaty
Ibrance
Enbrel
Paxlovid
Eliquis
Prevnar
Inlyta
Xeljanz
Chantix
Chantix Model
Lorbrena
Xalkori
Myfembree
etrasimod
elranatamab
giroctocogene
PF-06425090
VLA15
Sutent
Diflucan
Cardura
Vfend
Zyvox
Selzentry
PF868554
Aricept
Zithromax
fordadistrogene
Genotropin
Accupril
Fablyn
tanezumab
Acquisitions
IP
A
B
C
1
Main
2
Brand Name
Fablyn
3
Mechanism
SERM
4
Economics
LGND
5
Clinical Trials
6
PEARL
Martin Shkreli